MARK2 anticorps (N-Term)
MARK2
Reactivité: Humain, Souris, Rat, Singe
ELISA, WB, IF
Hôte: Lapin
Polyclonal
unconjugated
N° du produit ABIN3185464
-
-
Antigène
Voir toutes MARK2 Anticorps
-
MARK2
(MAP/microtubule Affinity-Regulating Kinase 2 (MARK2))
-
Épitope
-
N-Term
-
Reactivité
-
Humain, Souris, Rat, Singe
-
Hôte
-
Lapin
-
Clonalité
-
Polyclonal
-
Conjugué
-
Cet anticorp MARK2 est non-conjugé
-
Application
-
ELISA, Western Blotting (WB), Immunofluorescence (IF)
-
Specificité
-
MARK2 Polyclonal Antibody detects endogenous levels of MARK2 protein.
-
Attributs du produit
-
Rabbit Polyclonal to MARK2.
-
Purification
-
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
-
Synthesized peptide derived from the N-terminal region of human MARK2.
-
Isotype
-
IgG
-
Top Product
-
Discover our top product MARK2 Anticorps primaire
-
-
-
Indications d'application
-
WB 1:500-1:2000, IF 1:200-1:1000, ELISA 1:20000,
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Concentration
-
1 mg/mL
-
Buffer
-
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Agent conservateur
-
Sodium azide
-
Précaution d'utilisation
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
-
Stock
-
-20 °C
-
Stockage commentaire
-
Store at -20°C.
-
-
Antigène
-
MARK2
(MAP/microtubule Affinity-Regulating Kinase 2 (MARK2))
-
Autre désignation
-
MARK2 (MARK2 Produits)
-
Synonymes
-
anticorps EMK-1, anticorps EMK1, anticorps PAR-1, anticorps Par-1b, anticorps Par1b, anticorps AU024026, anticorps Emk, anticorps Par-1, anticorps mKIAA4207, anticorps microtubule affinity regulating kinase 2, anticorps MAP/microtubule affinity regulating kinase 2, anticorps MARK2, anticorps Mark2
-
Poids moléculaire
-
85 kDa
-
ID gène
-
2011
-
UniProt
-
Q7KZI7
-
Pathways
-
SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2
-